Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 2006, p. 3422-3425, Vol. 44, No. 9
0095-1137/06/$08.00+0 doi:10.1128/JCM.01269-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Anita Holzer,2,3
Esther Schelling,4
Jakob Zinsstag,4
Mahamat H. Hassane,1
Bhen S. Toguebaye,5
Ayayi J. Akakpo,6
Matthew Van Ert,7
Paul Keim,7,8
Leo Kenefic,7
Joachim Frey,2,3 and
Vincent Perreten2*
Laboratoire de Recherches Vétérinaires et Zootechniques, BP433 Farcha, N'Djaména, Chad,1 Swiss Tropical Institute, PO Box, CH-4002 Basel, Switzerland,4 Département de Biologie Animale, Université Cheik Anta Diop, Dakar, Sénégal,5 Département de Microbiologie, Ecole Inter-Etats des Sciences et Médecine Vétérinaire, Dakar, Sénégal,6 Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona 86011-5640,7 The Translational Genomics Research Institute (TGen), 400 N. Fifth Street Ste. 1600, Phoenix, Arizona 85004,8 National Centre for Anthrax,3 Institute of Veterinary Bacteriology, University of Berne, CH-3001 Bern, Switzerland2
Received 21 June 2006/ Accepted 16 July 2006
We genotyped 15 Bacillus anthracis isolates from Chad, Africa, using multiple-locus variable-number tandem repeat analysis and three additional direct-repeat markers. We identified two unique genotypes that represent a novel genetic lineage in the A cluster. Chadian isolates were susceptible to 11 antibiotics and free of 94 antibiotic resistance genes.
Present address: Institute of Medical Microbiology, Cantonal Hospital, CH-6000 Lucerne 16, Switzerland.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|